Langer Dennis
SEC-identified person · CIK 1274225 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Quoin Pharmaceuticals, Ltd. QNRX | Director | filed 2023–2026 |
| Myriad Genetics INC MYGN | Director | filed 2006–2022 |
| NTN Buzztime INC NTN | Director | filed 2021–2021 |
| Dicerna Pharmaceuticals Inc DRNA | Director | filed 2014–2019 |
| Pernix Therapeutics Holdings, INC. PTX | Director | filed 2016–2018 |
| Delcath Systems, INC. DTCH | Director | filed 2014–2015 |
| Myriad Pharmaceuticals, Inc. myrx | Director | filed 2009–2011 |
| Auxilium Pharmaceuticals INC AUXL | Director | filed 2007–2010 |
| Cytogen Corp NASD:CYTO | Director | filed 2006–2008 |
| Pharmacopeia INC PCOP | Director | filed 2007–2008 |
| Sirna Therapeutics INC RNAI | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.